IL111660A - Oligonucleoside compounds for effecting rnaseh-mediated cleavage of a target ribonucleic acid sequence and a pharmaceutical composition containing them - Google Patents
Oligonucleoside compounds for effecting rnaseh-mediated cleavage of a target ribonucleic acid sequence and a pharmaceutical composition containing themInfo
- Publication number
- IL111660A IL111660A IL11166094A IL11166094A IL111660A IL 111660 A IL111660 A IL 111660A IL 11166094 A IL11166094 A IL 11166094A IL 11166094 A IL11166094 A IL 11166094A IL 111660 A IL111660 A IL 111660A
- Authority
- IL
- Israel
- Prior art keywords
- rnaseh
- effecting
- acid sequence
- pharmaceutical composition
- composition containing
- Prior art date
Links
- 238000003776 cleavage reaction Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 230000001404 mediated effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229920002477 rna polymer Polymers 0.000 title 1
- 230000007017 scission Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Analytical Chemistry (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL12865894A IL128658A (en) | 1993-11-16 | 1994-11-16 | Oligonucleoside compounds for effecting rnaseh mediated cleavage of a target ribonucleic acid sequence and a pharmaceutical composition containing them |
| IL12865899A IL128658A0 (en) | 1993-11-16 | 1999-02-23 | Oligonucleoside compounds for effecting RNaseH mediated cleavage of a target ribonucleic acid sequence |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15401393A | 1993-11-16 | 1993-11-16 | |
| US15401493A | 1993-11-16 | 1993-11-16 | |
| US23377894A | 1994-04-26 | 1994-04-26 | |
| US23817794A | 1994-05-04 | 1994-05-04 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL111660A0 IL111660A0 (en) | 1995-01-24 |
| IL111660A true IL111660A (en) | 2005-05-17 |
Family
ID=27496113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11166094A IL111660A (en) | 1993-11-16 | 1994-11-16 | Oligonucleoside compounds for effecting rnaseh-mediated cleavage of a target ribonucleic acid sequence and a pharmaceutical composition containing them |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0743859A4 (en) |
| JP (1) | JPH09506248A (en) |
| KR (1) | KR960705589A (en) |
| AU (1) | AU689182B2 (en) |
| CA (1) | CA2176259A1 (en) |
| IL (1) | IL111660A (en) |
| NZ (1) | NZ277617A (en) |
| WO (1) | WO1995013834A1 (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996031600A1 (en) * | 1995-04-03 | 1996-10-10 | Hybridon, Inc. | Method of modulating gene expression without depleting complement |
| US6509149B2 (en) * | 1995-06-06 | 2003-01-21 | Hybridon, Inc. | HPV-specific oligonucleotides |
| US5898031A (en) * | 1996-06-06 | 1999-04-27 | Isis Pharmaceuticals, Inc. | Oligoribonucleotides for cleaving RNA |
| WO1999050409A1 (en) * | 1998-04-01 | 1999-10-07 | Hybridon, Inc. | Mixed-backbone oligonucleotides containing pops blocks to obtain reduced phosphorothioate content |
| US6277967B1 (en) | 1998-07-14 | 2001-08-21 | Isis Pharmaceuticals, Inc. | Carbohydrate or 2′-modified oligonucleotides having alternating internucleoside linkages |
| EP2361981B2 (en) † | 2000-03-30 | 2019-01-23 | The Whitehead Institute for Biomedical Research | RNA sequence-specific mediators of RNA interference |
| KR20080023768A (en) | 2000-03-30 | 2008-03-14 | 화이트헤드 인스티튜트 포 바이오메디칼 리서치 | RNA sequence specific mediator of RNA interference |
| KR100909681B1 (en) | 2000-12-01 | 2009-07-29 | 막스-플랑크-게젤샤프트 츄어 푀르더룽 데어 비쎈샤프텐 에.파우. | Small RNA molecules that mediate JR interference |
| US7452987B2 (en) * | 2002-08-05 | 2008-11-18 | Silence Therapeutics Aktiengesellschaft (Ag) | Interfering RNA molecules |
| HUE032289T2 (en) * | 2002-08-05 | 2017-09-28 | Silence Therapeutics Gmbh | Futher novel forms of interfering RNA molecules |
| US9827263B2 (en) | 2002-11-05 | 2017-11-28 | Ionis Pharmaceuticals, Inc. | 2′-methoxy substituted oligomeric compounds and compositions for use in gene modulations |
| US9150605B2 (en) | 2002-11-05 | 2015-10-06 | Isis Pharmaceuticals, Inc. | Compositions comprising alternating 2′-modified nucleosides for use in gene modulation |
| US9150606B2 (en) | 2002-11-05 | 2015-10-06 | Isis Pharmaceuticals, Inc. | Compositions comprising alternating 2'-modified nucleosides for use in gene modulation |
| EP3205725B1 (en) * | 2011-08-11 | 2019-03-27 | Ionis Pharmaceuticals, Inc. | Selective antisense compounds and uses thereof |
| WO2018051762A1 (en) * | 2016-09-14 | 2018-03-22 | レナセラピューティクス株式会社 | Antisense oligonucleotide with reduced side effects |
| KR20220070227A (en) * | 2019-09-19 | 2022-05-30 | 수디르 아그라왈 | Compounds and methods available for modulating gene splicing |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5212295A (en) * | 1990-01-11 | 1993-05-18 | Isis Pharmaceuticals | Monomers for preparation of oligonucleotides having chiral phosphorus linkages |
| US5149797A (en) * | 1990-02-15 | 1992-09-22 | The Worcester Foundation For Experimental Biology | Method of site-specific alteration of rna and production of encoded polypeptides |
| KR940703846A (en) * | 1991-12-24 | 1994-12-12 | 비. 린네 파샬 | GAPED 2 'MODIFED OLIGONUCLEOTIDES |
-
1994
- 1994-11-16 IL IL11166094A patent/IL111660A/en not_active IP Right Cessation
- 1994-11-16 WO PCT/US1994/013387 patent/WO1995013834A1/en not_active Ceased
- 1994-11-16 NZ NZ277617A patent/NZ277617A/en unknown
- 1994-11-16 EP EP95904098A patent/EP0743859A4/en not_active Withdrawn
- 1994-11-16 AU AU12916/95A patent/AU689182B2/en not_active Ceased
- 1994-11-16 JP JP7514646A patent/JPH09506248A/en active Pending
- 1994-11-16 CA CA002176259A patent/CA2176259A1/en not_active Abandoned
- 1994-11-16 KR KR1019960702552A patent/KR960705589A/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JPH09506248A (en) | 1997-06-24 |
| AU1291695A (en) | 1995-06-06 |
| CA2176259A1 (en) | 1995-05-26 |
| NZ277617A (en) | 1998-01-26 |
| WO1995013834A1 (en) | 1995-05-26 |
| EP0743859A1 (en) | 1996-11-27 |
| IL111660A0 (en) | 1995-01-24 |
| KR960705589A (en) | 1996-11-08 |
| EP0743859A4 (en) | 1998-10-21 |
| AU689182B2 (en) | 1998-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL111660A (en) | Oligonucleoside compounds for effecting rnaseh-mediated cleavage of a target ribonucleic acid sequence and a pharmaceutical composition containing them | |
| AU3455297A (en) | Pharmaceutical composition containing acid addition salt of basic drug | |
| ZA937502B (en) | Carboxylic acid derivatives pharmaceutical compositions containing these compounds and processes for preparing them | |
| ZA939230B (en) | Carboxylic acid derivatives pharmaceutical compositions containing these compounds and processes for preparing them | |
| IL75586A0 (en) | Pharmaceutical compositions containing indole-2-alkanoic acids and derivatives thereof,and certain such novel compounds | |
| HUT71106A (en) | Propenoic acid derivatives, pharmaceutical compositions containing them and process for their preparation | |
| ZA934090B (en) | Biphenyl derivatives pharmaceutical compositions containing these compounds and processes for preparing them | |
| HU200177B (en) | Process for producing thiazolidinecarboxylic acids and pharmaceutical compositions comprising such compounds | |
| IL115072A (en) | Pharmaceutical compositions containing substituted 4-phenyl-6-amino-nicotinic acid derivatives their preparation some such new compounds and process for their preparation | |
| AU5706486A (en) | Pharmaceutical compositions containing pyridinone compounds | |
| IL110157A (en) | (1-Heteroazolyl-1-heterocyclyl) alkane derivatives a process for their preparation and pharmaceutical compositions containing them | |
| HUT72319A (en) | Epoxy-succinic acid derivatives, pharmaceutical compositions containing them and process for their preparation | |
| IL80820A0 (en) | Imidazopyridazinealkenoic acid amides,processes and intermediate compounds for their preparation and pharmaceutical compositions containing them | |
| AU6217186A (en) | Pharmaceutical composition of desferrioxamine b or desferriferrithiocine for malaria treatment | |
| ZA966154B (en) | Aminophenylphosphonic acid compounds process for preparing them and pharmaceutical compositions containing them | |
| AU610175B2 (en) | Pharmaceutical composition comprising a compound containing sulfhydryl group(s) for the treatment of otitis | |
| ZA933638B (en) | Heterocyclic compounds a process for the preparation thereof and pharmaceutical compositions containing them | |
| ZA98440B (en) | Compounds of boronic acids a process for their preparation and pharmaceutical compositions containing them | |
| IL108920A0 (en) | Acyloxyhexanoic acid derivatives and pharmaceutical compositions containing them | |
| AU4959497A (en) | Pharmaceutical composition containing bismuth-polyacrylic acid compounds | |
| IL128658A (en) | Oligonucleoside compounds for effecting rnaseh mediated cleavage of a target ribonucleic acid sequence and a pharmaceutical composition containing them | |
| AU6190594A (en) | New substituted benzodioxins, a process for their preparation and pharmaceutical compositions containing them | |
| HU9400325D0 (en) | Process for producing amino-ascorbic acid derivatives and pharmaceutical compositions containing them | |
| ZA94368B (en) | Amino acid derivatives pharmaceutical compositions containing these compound and processes for their preparation | |
| EP0564775A3 (en) | Process for pharmaceutical grade high purity iodeoxycholic acid preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM9K | Patent not in force due to non-payment of renewal fees |